BRAXF News and Press, Braxia Scientific Corp From 01/27/23

Strategic transaction assembles an experienced management and scientific team world-renowned in mental health treatment, research and development Establishes large footprint of 17 specialized mental health clinics across North America, enhanced by a telehealth platform expected to extend acces...

Toronto, Ontario--(Newsfile Corp. - January 10, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC PINK: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company"), a medical research company providing psychiatric, innovative ketamine and psilocybin treatments for mental health disorders, is proud ...

LOS ANGELES, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) , is proud to announce it has signed a Letter of Intent entering into a partnership with Braxia Scientific Corp. (“Braxia S...

Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America Canada NewsWire Braxia Health clinic ketamine treatments up 34.5% YoY in Q2 2023 and revenue up 18% YoY Expan...

Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders Canada NewsWire TORONTO , Nov. 1, 2022 /CNW/ - Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical res...

KetaMD Expands Access to Breakthrough Ketamine Therapy in Florida to Battle the Growing Mental Health Crisis and Shortage of Mental Health Care Providers Canada NewsWire Patients Can Download the KetaMD Mobile App and Sign Up Anytime Through KetaMD.com to Access Keta...

Braxia Scientific Announces Board Appointment Canada NewsWire TORONTO , Sept. 21, 2022 /CNW/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960) a medical research and telemedicine company with clinics p...

Braxia Scientific Launches KetaMD in Florida; First Patients Complete Initial Virtual Ketamine Treatments At-Home Canada NewsWire TORONTO , Sept. 12, 2022 /CNW Telbec/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company") (CSE: BRAX) (OTC: BRA...

Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 Canada NewsWire TORONTO , Sept. 9, 2022 /CNW/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: ...

Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U.S. Increasing Treatment Access for Mental Health Patients Canada NewsWire TORONTO , Aug. 29, 2022 /CNW/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX...